Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR) — Income statement
Revenue, gross profit, operating income, net income, and EPS for Dr. Sulaiman Al Habib Medical Services Group Company — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 13,707↑22.4% | 11,200↑17.8% | 9,508↑14.4% | 8,311↑14.6% | 7,250 | |
| Cost of Revenue | 9,500↑27.4% | 7,456↑18.5% | 6,292↑13.1% | 5,563↑13.1% | 4,920 | |
| Gross Profit | 4,207↑12.4% | 3,744↑15.1% | 3,254↑18.4% | 2,748↑17.9% | 2,330 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 224↑43.2% | 156↑0.1% | 156↑17.2% | 133↑29.8% | 103 | |
| Selling & Marketing Expenses | 119↑50.3% | 79↑36.3% | 58↑18.1% | 49↑40.6% | 35 | |
| SG&A Expenses | 342↑45.6% | 235↑9.9% | 214↑17.5% | 182↑32.5% | 137 | |
| Other Expenses | 1,246↑8.1% | 1,153 | 0.00↓100.0% | 854↑19.3% | 716 | |
| Operating Expenses | 1,588↑14.4% | 1,388↑26.7% | 1,096↑5.8% | 1,036↑21.4% | 853 | |
| Total Costs & Expenses | 11,088↑25.4% | 8,844↑19.3% | 7,413↑12.3% | 6,599↑14.3% | 5,774 | |
| Operating Results | ||||||
| Operating Income | 2,639↑12.0% | 2,356↑12.4% | 2,096↑23.2% | 1,700↑16.0% | 1,466 | |
| Depreciation & Amortization | 672↑59.6% | 421↑34.6% | 313↑1.1% | 309↓1.8% | 315 | |
| EBITDA | 3,311↑10.7% | 2,992↑17.2% | 2,553↑18.9% | 2,147↑15.6% | 1,857 | |
| EBIT | 2,639↑2.5% | 2,576↑15.0% | 2,240↑21.3% | 1,846↑19.9% | 1,539 | |
| Interest & Other Income | ||||||
| Net Interest Income | -306↓149.5% | -123↓6850.4% | -2↑91.2% | -20↑47.9% | -39 | |
| Interest Income | 53↓7.1% | 57↓30.9% | 82↑101.7% | 41↑311.2% | 10 | |
| Interest Expense | 359↑100.0% | 180↑114.0% | 84↑37.8% | 61↑25.3% | 49 | |
| Non-Operating Income | -219↑0.3% | -219↓51.9% | -144↑0.7% | -146↓99.1% | -73 | |
| Other Income / Expenses | -120↓312.0% | 57↓23.9% | 74↓22.7% | 96↑173.3% | 35 | |
| Income Before Tax | 2,519↑4.4% | 2,413↑11.2% | 2,170↑20.8% | 1,797↑19.7% | 1,501 | |
| Income Tax Expense | 28↓35.6% | 43↓37.4% | 69↓36.4% | 108↓5.6% | 114 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 2,492↑5.1% | 2,370↑12.8% | 2,101↑25.9% | 1,669↑21.0% | 1,380 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 2,401↑3.7% | 2,315↑13.2% | 2,046↑23.9% | 1,651↑19.9% | 1,377 | |
| Bottom-Line Net Income | 2,401↑3.7% | 2,315↑13.2% | 2,046↑23.9% | 1,651↑19.9% | 1,377 | |
| EPS (Basic) | 6.86↑3.8% | 6.61↑13.0% | 5.85↑23.9% | 4.72↑20.1% | 3.93 | |
| EPS (Diluted) | 6.86↑3.8% | 6.61↑13.0% | 5.85↑23.9% | 4.72↑20.1% | 3.93 | |
| Weighted Average Shares | 350↑0.0% | 350↑0.0% | 350↑0.0% | 350↑0.0% | 350 | |
| Weighted Average Diluted Shares | 350↑0.0% | 350↑0.0% | 350↑0.0% | 350↑0.0% | 350 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.